Literature DB >> 25447581

Post-operative kinetics of procalcitonin after lung transplantation.

Mathieu Desmard1, Abdel Benbara2, Sandrine Boudinet2, Herve Mal3, Monique Dehoux4, Gabriel Thabut3, Philippe Montravers2.   

Abstract

BACKGROUND: Post-operative infections are a major complication after lung transplantation (LT). Early bacterial pneumonia worsens the prognosis of LT. Procalcitonin (PCT) has been proposed as an early and rapid laboratory marker of infection and sepsis. PCT could be a useful biomarker of pulmonary infection after LT, but the early kinetics of PCT in this setting are unknown. We evaluated the kinetics of PCT and the impact of respiratory tract infection on PCT concentrations.
METHODS: Over a 12-month period, PCT concentrations were determined daily in each patient admitted to our ICU for LT. Epidemiologic, clinical, laboratory and outcome data were obtained. A diagnosis of respiratory tract infection was suspected on clinical examination and confirmed by microbiologic culture.
RESULTS: Twenty-six consecutive patients were included and 397 blood samples were obtained (13 [range 4 to 66] samples per patient). Plasma PCT reached a peak in the first 24 hours post-transplantation (5.72 [0.11 to 93.8] ng/ml), with a progressive decline over the first 7 post-operative days. Doubling of plasma PCT levels after an initial decrease was significantly associated with respiratory tract infection in transplanted patients (RR = 4.2 95% CI [1.95 to 9.03]).
CONCLUSIONS: A non-specific increase in PCT values was observed during the first week post-LT. In combination with microbiologic cultures, PCT assays may be useful after the first post-operative week as an aid in the diagnosis of bacterial pulmonary infection.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarker; kinetics; lung transplantation; primary graft dysfunction; procalcitonin; pulmonary infection

Mesh:

Substances:

Year:  2014        PMID: 25447581     DOI: 10.1016/j.healun.2014.09.025

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

1.  Role of biomarkers in early infectious complications after lung transplantation.

Authors:  Borja Suberviola; Luzdivina Rellan; Jordi Riera; Reyes Iranzo; Ascension Garcia Campos; Juan Carlos Robles; Rosario Vicente; Eduardo Miñambres; Miguel Santibanez
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

2.  Procalcitonin for infections in the first week after pediatric liver transplantation.

Authors:  Vladimir L Cousin; Kalinka Lambert; Shahar Trabelsi; Annick Galetto-Lacour; Klara M Posfay-Barbe; Barbara E Wildhaber; Valérie A McLin
Journal:  BMC Infect Dis       Date:  2017-02-15       Impact factor: 3.090

3.  Morbidity and mortality related to pneumonia and TRACHEOBRONCHITIS in ICU after lung transplantation.

Authors:  Sebastien Tanaka; Claire Geneve; Gianpiero Tebano; Nathalie Grall; Pascal Piednoir; Régis Bronchard; Mathieu Godement; Enora Atchade; Pascal Augustin; Herve Mal; Yves Castier; Philippe Montravers; Mathieu Desmard
Journal:  BMC Pulm Med       Date:  2018-03-05       Impact factor: 3.317

4.  Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Authors:  Daniel E Dulek; Nicolas J Mueller
Journal:  Clin Transplant       Date:  2019-04-23       Impact factor: 2.863

Review 5.  Bacterial infections in lung transplantation.

Authors:  Margaret McCort; Erica MacKenzie; Kenneth Pursell; David Pitrak
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

6.  The Airway Microbiota Signatures of Infection and Rejection in Lung Transplant Recipients.

Authors:  Jin Su; Chun-Xi Li; Hai-Yue Liu; Chun-Rong Ju; Chang-Xuan You; Jian-Xing He; Qiao-Yan Lian; Ao Chen; Zhi-Xuan You; Kun Li; Yu-Hang Cai; Yan-Xia Lin; Jian-Bing Pan; Guo-Xia Zhang
Journal:  Microbiol Spectr       Date:  2022-04-13

7.  Diagnostic Value of Procalcitonin in Transplant Patients Receiving Immunosuppressant Drugs: A Retrospective Electronic Medical Record-Based Analysis.

Authors:  Hyojin Chae; Nicholas Bevins; Gregory B Seymann; Robert L Fitzgerald
Journal:  Am J Clin Pathol       Date:  2021-11-08       Impact factor: 5.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.